CASE Letter to US Senate Urging Support for Pro-IP PREVAIL and PERA Bills
November 14, 2024 The Honorable Dick Durbin, Chairman United States Senate Committee on the Judiciary 224 Dirksen Senate Office Building...
November 14, 2024 The Honorable Dick Durbin, Chairman United States Senate Committee on the Judiciary 224 Dirksen Senate Office Building...
With World Intellectual Property (IP) Day here, it is important to recognize recent wins for IP and its role...
February 15, 2024 (Alexandria, Virginia) — Today, Consumer Action for a Strong Economy (CASE) released a letter from a...
July 12, 2022 Patent-assertion entities, also known as patent trolls, are abusing the International Trade Commission (ITC) process to...
Gerard Scimeca – Chairman, CASE October 29, 2020 Some court battles, like some movies, are better off without a sequel....
Gerard Scimeca – Chairman, CASE July 10, 2020 Every day, dozens of government agencies implement the laws and regulations of...
Gerard Scimeca – Chairman, CASE April 17, 2020 As the coronavirus pandemic lays siege to everyday life, mobile technology...
Gerard Scimeca – Vice President, CASE December 6, 2019 The teenager unable to look up from her phone has quickly...
Gerard Scimeca – Chairman, CASE October 4, 2019 America has long led the world in groundbreaking innovation and life-altering inventions....
Gerard Scimeca – Chairman, CASE September 14, 2019 The Godfather author Mario Puzo once said one lawyer with a briefcase can...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers